| Summary of Earnings Per Share |
The following table summarizes the weighted-average number of basic common shares outstanding and the calculation of basic earnings per share for the periods presented (unaudited in thousands, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, |
|
For the Six Months Ended March 31, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| Numerator |
|
|
|
|
|
|
|
| Net income (loss) attributable to common stockholders |
$ |
(1,124) |
|
|
$ |
(5,481) |
|
|
$ |
8,719 |
|
|
$ |
(3,589) |
|
| Denominator |
|
|
|
|
|
|
|
| Weighted average number of common shares outstanding, basic |
51,938,216 |
|
|
51,827,365 |
|
|
51,915,069 |
|
|
51,826,143 |
|
| Net income (loss) per common share attributable to common stockholders, basic |
$ |
(0.02) |
|
|
$ |
(0.11) |
|
|
$ |
0.17 |
|
|
$ |
(0.07) |
|
|
|
|
|
|
|
|
|
The following table summarizes the calculation of the weighted-average number of diluted common shares outstanding and the calculation of diluted earnings per share for the periods presented (unaudited in thousands, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended March 31, |
|
For the Six Months Ended March 31, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
| Numerator |
|
|
|
|
|
|
|
| Net income (loss) attributable to common stockholders |
$ |
(1,124) |
|
|
$ |
(5,481) |
|
|
$ |
8,719 |
|
|
$ |
(3,589) |
|
| Denominator |
|
|
|
|
|
|
|
| Weighted average number of basic common shares outstanding, basic |
51,938,216 |
|
|
51,827,365 |
|
|
51,915,069 |
|
|
51,826,143 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock grants |
— |
|
|
— |
|
|
608,031 |
|
|
— |
|
| Weighted average number of diluted common shares outstanding: |
51,938,216 |
|
|
51,827,365 |
|
|
52,523,100 |
|
|
51,826,143 |
|
| Net income (loss) per diluted common share attributable to common stockholders |
$ |
(0.02) |
|
|
$ |
(0.11) |
|
|
$ |
0.17 |
|
|
$ |
(0.07) |
|
|
|
|
|
|
|
|
|
|